Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Drug for Ulcerative Colitis Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Drug for Ulcerative Colitis Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Oral
      • 1.3.3 Injection
    • 1.4 Market Segment by Application
      • 1.4.1 Global Drug for Ulcerative Colitis Market Share by Application (2019-2025)
      • 1.4.2 Hospital
      • 1.4.3 Drugs Stores
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Drug for Ulcerative Colitis Market Size
      • 2.1.1 Global Drug for Ulcerative Colitis Revenue 2014-2025
      • 2.1.2 Global Drug for Ulcerative Colitis Sales 2014-2025
    • 2.2 Drug for Ulcerative Colitis Growth Rate by Regions
      • 2.2.1 Global Drug for Ulcerative Colitis Sales by Regions 2014-2019
      • 2.2.2 Global Drug for Ulcerative Colitis Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Drug for Ulcerative Colitis Sales by Manufacturers
      • 3.1.1 Drug for Ulcerative Colitis Sales by Manufacturers 2014-2019
      • 3.1.2 Drug for Ulcerative Colitis Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Drug for Ulcerative Colitis Revenue by Manufacturers (2014-2019)
      • 3.2.2 Drug for Ulcerative Colitis Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Drug for Ulcerative Colitis Market Concentration Ratio (CR5 and HHI)
    • 3.3 Drug for Ulcerative Colitis Price by Manufacturers
    • 3.4 Key Manufacturers Drug for Ulcerative Colitis Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Drug for Ulcerative Colitis Market
    • 3.6 Key Manufacturers Drug for Ulcerative Colitis Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Oral Sales and Revenue (2014-2019)
      • 4.1.2 Injection Sales and Revenue (2014-2019)
    • 4.2 Global Drug for Ulcerative Colitis Sales Market Share by Type
    • 4.3 Global Drug for Ulcerative Colitis Revenue Market Share by Type
    • 4.4 Drug for Ulcerative Colitis Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Drug for Ulcerative Colitis Sales by Application

    6 United States

    • 6.1 United States Drug for Ulcerative Colitis Breakdown Data by Company
    • 6.2 United States Drug for Ulcerative Colitis Breakdown Data by Type
    • 6.3 United States Drug for Ulcerative Colitis Breakdown Data by Application

    7 European Union

    • 7.1 European Union Drug for Ulcerative Colitis Breakdown Data by Company
    • 7.2 European Union Drug for Ulcerative Colitis Breakdown Data by Type
    • 7.3 European Union Drug for Ulcerative Colitis Breakdown Data by Application

    8 China

    • 8.1 China Drug for Ulcerative Colitis Breakdown Data by Company
    • 8.2 China Drug for Ulcerative Colitis Breakdown Data by Type
    • 8.3 China Drug for Ulcerative Colitis Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Drug for Ulcerative Colitis Breakdown Data by Company
    • 9.2 Rest of World Drug for Ulcerative Colitis Breakdown Data by Type
    • 9.3 Rest of World Drug for Ulcerative Colitis Breakdown Data by Application
    • 9.4 Rest of World Drug for Ulcerative Colitis Breakdown Data by Countries
      • 9.4.1 Rest of World Drug for Ulcerative Colitis Sales by Countries
      • 9.4.2 Rest of World Drug for Ulcerative Colitis Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Johnson & Johnson.
      • 10.1.1 Johnson & Johnson. Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Drug for Ulcerative Colitis
      • 10.1.4 Drug for Ulcerative Colitis Product Introduction
      • 10.1.5 Johnson & Johnson. Recent Development
    • 10.2 AbbVie
      • 10.2.1 AbbVie Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Drug for Ulcerative Colitis
      • 10.2.4 Drug for Ulcerative Colitis Product Introduction
      • 10.2.5 AbbVie Recent Development
    • 10.3 Takeda Pharmaceuticals
      • 10.3.1 Takeda Pharmaceuticals Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Drug for Ulcerative Colitis
      • 10.3.4 Drug for Ulcerative Colitis Product Introduction
      • 10.3.5 Takeda Pharmaceuticals Recent Development
    • 10.4 Roche
      • 10.4.1 Roche Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Drug for Ulcerative Colitis
      • 10.4.4 Drug for Ulcerative Colitis Product Introduction
      • 10.4.5 Roche Recent Development
    • 10.5 Warner Chilcott
      • 10.5.1 Warner Chilcott Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Drug for Ulcerative Colitis
      • 10.5.4 Drug for Ulcerative Colitis Product Introduction
      • 10.5.5 Warner Chilcott Recent Development
    • 10.6 Salix Pharmaceuticals/Santarus
      • 10.6.1 Salix Pharmaceuticals/Santarus Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Drug for Ulcerative Colitis
      • 10.6.4 Drug for Ulcerative Colitis Product Introduction
      • 10.6.5 Salix Pharmaceuticals/Santarus Recent Development
    • 10.7 Shire Pharmaceuticals
      • 10.7.1 Shire Pharmaceuticals Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Drug for Ulcerative Colitis
      • 10.7.4 Drug for Ulcerative Colitis Product Introduction
      • 10.7.5 Shire Pharmaceuticals Recent Development
    • 10.8 Ferring Pharmaceuticals
      • 10.8.1 Ferring Pharmaceuticals Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Drug for Ulcerative Colitis
      • 10.8.4 Drug for Ulcerative Colitis Product Introduction
      • 10.8.5 Ferring Pharmaceuticals Recent Development
    • 10.9 Pfizer
      • 10.9.1 Pfizer Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Drug for Ulcerative Colitis
      • 10.9.4 Drug for Ulcerative Colitis Product Introduction
      • 10.9.5 Pfizer Recent Development
    • 10.10 InDeX Pharmaceuticals
      • 10.10.1 InDeX Pharmaceuticals Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Drug for Ulcerative Colitis
      • 10.10.4 Drug for Ulcerative Colitis Product Introduction
      • 10.10.5 InDeX Pharmaceuticals Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Drug for Ulcerative Colitis Sales Channels
      • 11.2.2 Drug for Ulcerative Colitis Distributors
    • 11.3 Drug for Ulcerative Colitis Customers

    12 Market Forecast

    • 12.1 Global Drug for Ulcerative Colitis Sales and Revenue Forecast 2019-2025
    • 12.2 Global Drug for Ulcerative Colitis Sales Forecast by Type
    • 12.3 Global Drug for Ulcerative Colitis Sales Forecast by Application
    • 12.4 Drug for Ulcerative Colitis Forecast by Regions
      • 12.4.1 Global Drug for Ulcerative Colitis Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Drug for Ulcerative Colitis Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Anti-inflammatory drugs are often the first step in the treatment of ulcerative colitis. They include: 5-aminosalicylates. Examples of this type of medication includesulfasalazine (Azulfidine), mesalamine (Asacol HD, Delzicol, others), balsalazide (Colazal) and olsalazine (Dipentum).
      In 2019, the market size of Drug for Ulcerative Colitis is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Drug for Ulcerative Colitis.

      This report studies the global market size of Drug for Ulcerative Colitis, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Drug for Ulcerative Colitis sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Johnson & Johnson.
      AbbVie
      Takeda Pharmaceuticals
      Roche
      Warner Chilcott
      Salix Pharmaceuticals/Santarus
      Shire Pharmaceuticals
      Ferring Pharmaceuticals
      Pfizer
      InDeX Pharmaceuticals

      Market Segment by Product Type
      Oral
      Injection

      Market Segment by Application
      Hospital
      Drugs Stores

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Drug for Ulcerative Colitis status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Drug for Ulcerative Colitis manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Drug for Ulcerative Colitis are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now